Zobrazeno 1 - 10
of 17
pro vyhledávání: '"R. P. Ketterling"'
Autor:
K. H. Begna, X. Xu, N. Gangat, H. Alkhateeb, M. M. Patnaik, A. Al-Kali, M. A. Elliott, W. J. Hogan, M. R. Litzow, C. C. Hook, A. P. Wolanskyj-Spinner, A. Mangaonkar, R. He, A. Pardanani, M. Shah, R. P. Ketterling, A. Tefferi
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 4, Pp 1-4 (2022)
Externí odkaz:
https://doaj.org/article/b2b5bce960224cf2bc1e809d5f6873fb
Autor:
K. H. Begna, J. Kittur, N. Gangat, H. Alkhateeb, M. S. Patnaik, A. Al-Kali, M. A. Elliott, W. J. Hogan, M. R. Litzow, A. Pardanani, C. A. Hanson, R. P. Ketterling, A. Tefferi
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 1, Pp 1-8 (2022)
Abstract We sought to appraise the value of overall response and salvage chemotherapy, inclusive of allogeneic hematopoietic stem cell transplant (AHSCT), in primary refractory acute myeloid leukemia (prAML). For establishing consistency in clinical
Externí odkaz:
https://doaj.org/article/4883604e468f479bbb604b57a39becff
Autor:
M M, Patnaik, E, Padron, R R, LaBorde, T L, Lasho, C M, Finke, C A, Hanson, J M, Hodnefield, R A, Knudson, R P, Ketterling, A, Al-kali, A, Pardanani, N A, Ali, R S, Komrokji, R S, Komroji, A, Tefferi
Publikováno v:
Leukemia. 27:1504-1510
We evaluated the prognostic relevance of several clinical and laboratory parameters in 226 Mayo Clinic patients with chronic myelomonocytic leukemia (CMML): 152 (67%) males and median age 71 years. At a median follow-up of 15 months, 166 (73%) deaths
Autor:
S. M. Jalal, R. P. Ketterling
Publikováno v:
Atlas of Human Chromosome Heteromorphisms ISBN: 9789048162963
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93b69b55c7ae9b9be4fa800526e0eede
https://doi.org/10.1007/978-94-017-0433-5_6
https://doi.org/10.1007/978-94-017-0433-5_6
Publikováno v:
Prenatal diagnosis. 20(2)
We describe two families in which an inherited interstitial deletion is present without apparent associated phenotypic abnormalities. The first deletion was discovered in a 19-year-old male with a previously diagnosed peroxisomal disorder. High-resol
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 5(1)
We report the second confirmed case of the haemophilia B 'Brandenberg' phenotype. At the time of testing, patient HB530 was a 17-year-old post-puberty male with a persistent, clinically severe bleeding disorder and markedly reduced plasma procoagulan
Publikováno v:
Human mutation. 13(3)
Small consensus sequences have been defined for RNA splicing, but questions about splicing in humans remain unanswered. Analysis of germline mutations in the factor IX gene offers a highly advantageous system for studying the mutational process in hu
Autor:
J A, Heit, E C, Thorland, R P, Ketterling, T J, Lind, T M, Daniels, R E, Zapata, S M, Ordonez, C K, Kasper, S S, Sommer
Publikováno v:
Human mutation. 11(5)
Exogenous (e.g., environmental) mutagens produce characteristic patterns of mutation. In contrast, endogenous mutation processes likely are associated with an invariant pattern of mutation. Analysis of factor IX gene mutations among large samples of
Autor:
E C, Thorland, B G, Weinshenker, J Z, Liu, R P, Ketterling, E L, Vielhaber, C K, Kasper, R, Ambriz, R, Paredes, S S, Sommer
Publikováno v:
Thrombosis and haemostasis. 74(6)
Germline mutations in patients with hemophilia B generally have arisen within the past 150 years. Evidence suggests that these germline mutations generally result from endogenous processes. However, a unique pattern would be expected if a population
Publikováno v:
American journal of human genetics. 54(5)
We have identified eight independent transversions at CpG in 290 consecutive families with hemophilia B. These eight transversions account for 16.3% of all independent transversions in our sample, yet the expected frequency of CpG transversions at ra